Safety of continuous anticoagulation with dabigatran during implantation of cardiac rhythm devices

American Journal of Cardiology

Volumn 111, Issue 8, 2013, Pages 1165-1168

  Rowley, Christopher P ^a   Bernard, Michael L ^a   Brabham, William W ^a   Netzler, Peter C ^a   Sidney, Darren S ^a   Cuoco, Frank ^a   Sturdivant, J Lacy ^a   Leman, Robert B ^a   Wharton, J Marcus ^a   Gold, Michael R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DABIGATRAN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CARDIAC IMPLANT; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; DRUG DOSE REDUCTION; DRUG SAFETY; ELECTRONICS; FEMALE; HEART INFARCTION; HEART RHYTHM; HEMATOMA; HOSPITALIZATION; HUMAN; IMPLANTATION; LUNG EMBOLISM; MALE; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK;

AGED; ANTITHROMBINS; BENZIMIDAZOLES; BETA-ALANINE; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES;

EID: 84875858760     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.12.046     Document Type: Article

References (24)

1. E. Jamula, J.D. Douketis, and S. Schulman Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide J Thromb Haemost 6 2008 1615 1621
2. G.F. Michaud, F. Pelosi Jr., M.D. Noble, B.P. Knight, F. Morady, and S.A. Strickberger A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation J Am Coll Cardiol 35 2000 1915 1918
3. A.S. al-Khadra Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients Pacing Clin Electrophysiol 26 2003 511 514
4. D.J. Milic, Z.D. Perisic, S.S. Zivic, Z.A. Stanojkovic, A.M. Stojkovic, N.D. Karanovic, N.H. Krstic, and S.S. Salinger Prevention of pocket related complications with fibrin sealant in patients undergoing pacemaker implantation who are receiving anticoagulant treatment Europace 7 2005 374 379
5. M.C. Giudici, D.L. Paul, P. Bontu, and S.S. Barold Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy Pacing Clin Electrophysiol 27 2004 358 360
6. C. Hammerstingl, and H. Omran Perioperative bridging of chronic oral anticoagulation in patients undergoing pacemaker implantation - a study in 200 patients Europace 13 2011 1304 1310
7. J. de Bono, S. Nazir, N. Ruparelia, Y. Bashir, T. Betts, and K. Rajappan Perioperative management of anticoagulation during device implantation - the UK perspective Pacing Clin Electrophysiol 33 2010 389 393
8. J.M. Tolosana, P. Berne, L. Mont, M. Heras, A. Berruezo, J. Monteagudo, D. Tamborero, B. Benito, and J. Brugada Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial Eur Heart J 30 2009 1880 1884
9. I. Ahmed, E. Gertner, W.B. Nelson, C.M. House, R. Dahiya, C.P. Anderson, D.G. Benditt, and D.W. Zhu Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation Heart Rhythm 7 2010 745 749
10. D.J. Goldstein, W. Losquadro, and H.M. Spotnitz Outpatient pacemaker procedures in orally anticoagulated patients Pacing Clin Electrophysiol 21 1998 1730 1734
11. M.L. Bernard, M. Shotwell, P.J. Nietert, and M.R. Gold Meta-analysis of bleeding complications associated with cardiac rhythm device implantation Circ Arrhythm Electrophysiol 5 2012 468 474
12. H. Ghanbari, W.S. Phard, H. Al-Ameri, R. Latchamsetty, K. Jongnarngsin, T. Crawford, E. Good, A. Chugh, H. Oral, F. Bogun, F. Morady, and F. Pelosi Jr. Meta-analysis of safety and efficacy of uninterrupted warfarin compared to heparin-based bridging therapy during implantation of cardiac rhythm devices Am J Cardiol 110 2012 1482 1488
13. C. Marquie, G. De Geeter, D. Klug, C. Kouakam, F. Brigadeau, O. Jabourek, N. Trillot, D. Lacroix, and S. Kacet Post-operative use of heparin increases morbidity of pacemaker implantation Europace 8 2006 283 287
14. M. Robinson, J.S. Healey, J. Eikelboom, S. Schulman, C.A. Morillo, G.M. Nair, A. Baranchuk, S. Ribas, G. Evans, S.J. Connolly, and A.G. Turpie Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators Pacing Clin Electrophysiol 32 2009 378 382
15. A. Tischenko, L.J. Gula, R. Yee, G.J. Klein, A.C. Skanes, and A.D. Krahn Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular-weight heparin Am Heart J 158 2009 252 256
16. H.K. Li, F.C. Chen, R.F. Rea, S.J. Asirvatham, B.D. Powell, P.A. Friedman, W.K. Shen, P.A. Brady, D.J. Bradley, H.C. Lee, D.O. Hodge, J.P. Slusser, D.L. Hayes, and Y.M. Cha No increased bleeding events with continuation of oral anticoagulation therapy for patients undergoing cardiac device procedure Pacing Clin Electrophysiol 34 2011 868 874
17. D. Birnie, J.S. Healey, A. Krahn, V. Essebag, S. Sivakumaran, A. Tang, and C. Simpson Bridge or continue Coumadin for device surgery: a randomized controlled trial rationale and design Curr Opin Cardiol 24 2009 82 87
18. G.J. Hankey, and J.W. Eikelboom Dabigatran etexilate: a new oral thrombin inhibitor Circulation 123 2011 1436 1450
19. J.I. Weitz, D.J. Quinlan, and J.W. Eikelboom Periprocedural management and approach to bleeding in patients taking dabigatran Circulation 126 2012 2428 2432
20. S. Chen, J. Liu, W. Pan, S. Liu, Y. Su, J. Bai, W. Wang, and J. Ge Thromboembolic events during the perioperative period in patients undergoing permanent pacemaker implantation Clin Cardiol 35 2012 83 87
21. J.S. Healey, J. Eikelboom, J. Douketis, L. Wallentin, J. Oldgren, S. Yang, E. Themeles, H. Heidbuchle, A. Avezum, P. Reilly, S.J. Connolly, S. Yusuf, and M. Ezekowitz Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the randomized evaluation of long-term anticoagulation therapy (RE-LY) randomized trial Circulation 126 2012 343 348
22. U.K. Wiegand, D. LeJeune, F. Boguschewski, H. Bonnemeier, F. Eberhardt, H. Schunkert, and F. Bode Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy Chest 126 2004 1177 1186
23. M. Lamberts, J.B. Olesen, M.H. Ruwald, C.M. Hansen, D. Karasoy, S.L. Kristensen, L. Kober, C. Torp-Pedersen, G.H. Gislason, and M.L. Hansen Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study Circulation 126 2012 1185 1193
24. D. Lakkireddy, Y.M. Reddy, L. Di Biase, S.R. Vanga, P. Santangeli, V. Swarup, R. Pimentel, M.C. Mansour, A. D'Avila, J.E. Sanchez, J.D. Burkhardt, F. Chalhoub, P. Mohanty, J. Coffey, N. Shaik, G. Monir, V.Y. Reddy, J. Ruskin, and A. Natale Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry J Am Coll Cardiol 59 2012 1168 1174